Table 3 Line immunoassay (LIA) reactivity of antibeta2-glycoprotein I (aβ2GPI) domain 1 (D1) negative-D4/5 positive and D1 positive-D4/5 negative sera from patients (Pts) with antiphospholipid syndrome (APS)
aPL IgG reactivity by LIA (OD) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
aβ2GPI reactivity profile | Pt # | aCL | aPA | aPC | aPE | aPG | aPI | aPS | aAnV | aβ2GPI | aPT |
aD1 negative-aD4/5 positive | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 |
2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | 0 | |
3 | 0 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0 | |
5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34 | 0 | |
aD1 positive-aD4/5 negative* | 6 | 108 | 80 | 0 | 0 | 0 | 0 | 109 | 0 | 97 | 0 |
7 | 121 | 107 | 0 | 35 | 84 | 94 | 116 | 44 | 121 | 83 | |
8 | 87 | 45 | 0 | 0 | 41 | 58 | 92 | 0 | 65 | 0 | |
9 | 111 | 68 | 0 | 0 | 85 | 91 | 101 | 0 | 98 | 37 | |
10 | 136 | 107 | 0 | 0 | 109 | 117 | 131 | 33 | 123 | 80 | |
11 | 99 | 66 | 0 | 0 | 49 | 69 | 93 | 0 | 86 | 0 | |
12 | 136 | 104 | 0 | 0 | 99 | 94 | 121 | 56 | 123 | 82 | |
13 | 116 | 83 | 0 | 0 | 100 | 106 | 126 | 0 | 118 | 33 | |
14 | 135 | 121 | 0 | 0 | 91 | 106 | 121 | 0 | 116 | 50 | |